Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
On Oct. 21, 2015, the Second Circuit affirmed a 2014 decision by the NLRB overturning the terminations of two employees who had complained about their employer on Facebook.
Columns & Departments
Due to a med mal verdict, an ex-prisoner's estate receives $1.75 million .
Features
The Equipment Leasing and Finance Association (ELFA) has released its list of Top 10 Equipment Acquisition Trends for 2016.
Features
Normally, when a violation of the FCPA comes to mind, it looks a lot like this: A company, due to either corrupt intent or maybe just poor compliance practices, pays off a foreign official in return for some sort of business benefit. It's true that this is often how FCPA cases come to be, but not always.
Columns & Departments
Discussion of a late-year wave of hospital FCA settlements.
The U.S. Court of Appeals for the Ninth Circuit on Jan. 6 upheld a $20 million class action settlement that resolved privacy claims against Facebook Inc. over a feature that posted users names and images along with advertising promotions.
Columns & Departments
Analysis of a GM trial in which "Similar Incident" evidence was permitted.
The most significant effects that California Code of Regulations Title 24 has on a lease relates to which party will bear the cost of the upgrades required to make the space compliant with the legislation. Here's what you need to know.
Features
A recent Yahoo! Parenting article grouped a particular lawsuit under the larger rubric of "obstetric violence." But, what is "obstetric violence" and how does it fit into the modern American medical jurisprudence?
Features
The pharmaceutical industry has recently felt empowered and emboldened by one final court decision and another pending case that would seemingly allow companies to distribute, proactively, information about unapproved uses, i.e. , off-label, so long as the information is truthful and not misleading. However, companies must, nevertheless, consider potential product liability ramifications. There is no indication that, because firms may now be allowed certain latitude in one area, they are immune from product liability exposure.
